11:21 AM
 | 
May 23, 2018
 |  BC Innovations  |  Distillery Therapeutics

Neurology; musculoskeletal

INDICATION: Amyotrophic lateral sclerosis (ALS); musculoskeletal

In vitro, cell culture and fruit fly studies suggest promoting the expression of TNPO1 could help treat ALS caused by FUS mutations and multisystem proteinopathy caused by HNRNPA1 mutations. In vitro, TNPO1 decreased the formation of new toxic fibrils from...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >